|
1
|
Feldmann M, Brennan FM and Maini RN:
Rheumatoid arthritis. Cell. 85:307–310. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Brennan FM and McInnes IB: Evidence that
cytokines play a role in rheumatoid arthritis. J Clin Invest.
118:3537–3545. 2008. View
Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ritchlin C: Fibroblast biology. Effector
signals released by the synovial fibroblast in arthritis. Arthritis
Res. 2:356–360. 2000. View
Article : Google Scholar : PubMed/NCBI
|
|
4
|
Buchan G, Barrett K, Turner M, Chantry D,
Maini RN and Feldmann M: Interleukin-1 and tumour necrosis factor
mRNA expression in rheumatoid arthritis: prolonged production of
IL-1 alpha. Clin Exp Immunol. 73:449–455. 1988.PubMed/NCBI
|
|
5
|
Gabay C, Lamacchia C and Palmer G: IL-1
pathways in inflammation and human diseases. Nat Rev Rheumatol.
6:232–241. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Choy EH and Panayi GS: Cytokine pathways
and joint inflammation in rheumatoid arthritis. N Engl J Med.
344:907–916. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Nanki T, Hayashida K, El-Gabalawy HS, et
al: Stromal cell-derived factor-1-CXC chemokine receptor 4
interactions play a central role in CD4+ T cell
accumulation in rheumatoid arthritis synovium. J Immunol.
165:6590–6598. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Scott DL: Biologics-based therapy for the
treatment of rheumatoid arthritis. Clin Pharmacol Ther. 91:30–43.
2012. View Article : Google Scholar
|
|
9
|
Pruessmeyer J and Ludwig A: The good, the
bad and the ugly substrates for ADAM10 and ADAM17 in brain
pathology, inflammation and cancer. Semin Cell Dev Biol.
20:164–174. 2009. View Article : Google Scholar
|
|
10
|
Baren JP, Stewart GD, Stokes A, et al:
mRNA profiling of the cancer degradome in oesophago-gastric
adenocarcinoma. Br J Cancer. 107:143–149. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kuefer R, Day KC, Kleer CG, et al: ADAM15
disintegrin is associated with aggressive prostate and breast
cancer disease. Neoplasia. 8:319–329. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Lucas N and Day ML: The role of the
disintegrin metalloproteinase ADAM15 in prostate cancer
progression. J Cell Biochem. 106:967–974. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Böhm BB, Aigner T, Gehrsitz A, Blobel CP,
Kalden JR and Burkhardt H: Up-regulation of MDC15 (metargidin)
messenger RNA in human osteoarthritic cartilage. Arthritis Rheum.
42:1946–1950. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Böhm BB, Schirner A and Burkhardt H:
ADAM15 modulates outside-in signalling in chondrocyte-matrix
interactions. J Cell Mol Med. 13:2634–2644. 2009. View Article : Google Scholar
|
|
15
|
Böhm BB, Aigner T, Roy B, Brodie TA,
Blobel CP and Burkhardt H: Homeostatic effects of the
metalloproteinase disintegrin ADAM15 in degenerative cartilage
remodeling. Arthritis Rheum. 52:1100–1109. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Charrier-Hisamuddin L, Laboisse CL and
Merlin D: ADAM-15: a metalloprotease that mediates inflammation.
FASEB J. 22:641–653. 2008. View Article : Google Scholar
|
|
17
|
Komiya K, Enomoto H, Inoki I, et al:
Expression of ADAM15 in rheumatoid synovium: up-regulation by
vascular endothelial growth factor and possible implications for
angiogenesis. Arthritis Res Ther. 7:R1158–R1173. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Böhm BB, Aigner T, Blobel CP, Kalden JR
and Burkhardt H: Highly enhanced expression of the disintegrin
metalloproteinase MDC15 (metargidin) in rheumatoid synovial tissue.
Arthritis Rheum. 44:2046–2054. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Böhm BB, Freund I, Krause K, Kinne RW and
Burkhardt H: ADAM15 adds to apoptosis resistance of synovial
fibroblasts by modulating focal adhesion kinase signaling.
Arthritis Rheum. 65:2826–2834. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Yoshioka Y, Kozawa E, Urakawa H, et al:
Suppression of hyaluronan synthesis alleviates inflammatory
responses in murine arthritis and in human rheumatoid synovial
fibroblasts. Arthritis Rheum. 65:1160–1170. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Fried D, Böhm BB, Krause K and Burkhardt
H: ADAM15 protein amplifies focal adhesion kinase phosphorylation
under genotoxic stress conditions. J Biol Chem. 287:21214–21223.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Minakuchi Y, Takeshita F, Kosaka N, et al:
Atelocollagen-mediated synthetic small interfering RNA delivery for
effective gene silencing in vitro and in vivo. Nucleic Acids Res.
32:e1092004. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Li F, Li X, Kou L, Li Y, Meng F and Ma F:
SUMO-conjugating enzyme UBC9 promotes proliferation and migration
of fibroblast-like synoviocytes in rheumatoid arthritis.
Inflammation. 37:1134–1141. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Tarrant TK, Liu P, Rampersad RR, et al:
Decreased Th17 and antigen-specific humoral responses in
CX3 CR1-deficient mice in the collagen-induced arthritis
model. Arthritis Rheum. 64:1379–1387. 2012. View Article : Google Scholar
|
|
25
|
Nishikawa M, Myoui A, Tomita T, Takahi K,
Nampei A and Yoshikawa H: Prevention of the onset and progression
of collagen-induced arthritis in rats by the potent p38
mitogen-activated protein kinase inhibitor FR167653. Arthritis
Rheum. 48:2670–2681. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Chang SK, Gu Z and Brenner MB:
Fibroblast-like synoviocytes in inflammatory arthritis pathology:
the emerging role of cadherin-11. Immunol Rev. 233:256–266. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Afuwape AO, Kiriakidis S and Paleolog EM:
The role of the angiogenic molecule VEGF in the pathogenesis of
rheumatoid arthritis. Histol Histopathol. 17:961–972.
2002.PubMed/NCBI
|
|
28
|
Mori T, Miyamoto T, Yoshida H, et al:
IL-1beta and TNFalpha-initiated IL-6-STAT3 pathway is critical in
mediating inflammatory cytokines and RANKL expression in
inflammatory arthritis. Int Immunol. 23:701–712. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Feldmann M: Development of anti-TNF
therapy for rheumatoid arthritis. Nat Rev Immunol. 2:364–371. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Ehrenstein MR, Evans JG, Singh A, et al:
Compromised function of regulatory T cells in rheumatoid arthritis
and reversal by anti-TNFalpha therapy. J Exp Med. 200:277–285.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Folgueras AR, Pendas AM, Sanchez LM and
Lopez-Otin C: Matrix metalloproteinases in cancer: from new
functions to improved inhibition strategies. Int J Dev Biol.
48:411–424. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Okada Y, Gonoji Y, Nakanishi I, Nagase H
and Hayakawa T: Immunohistochemical demonstration of collagenase
and tissue inhibitor of metalloproteinases (TIMP) in synovial
lining cells of rheumatoid synovium. Virchows Arch B Cell Pathol
Incl Mol Pathol. 59:305–312. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Ding L, Guo D, Homandberg GA, Buckwalter
JA and Martin JA: A single blunt impact on cartilage promotes
fibronectin fragmentation and upregulates cartilage degrading
stromelysin-1/matrix metalloproteinase-3 in a bovine ex vivo model.
J Orthop Res. 32:811–818. 2014. View Article : Google Scholar : PubMed/NCBI
|
